Rhythm Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $48,502 | $32,704 | $41,830 | $33,251 |
Gross Profit | 42,959 | 29,056 | 38,043 | 29,423 |
EBITDA | -40,099 | -43,626 | -37,552 | -38,358 |
EBIT | -40,478 | -44,009 | -37,935 | -38,743 |
Net Income | -46,632 | -49,498 | -43,292 | -43,641 |
Net Change In Cash | 48,502 | 32,704 | 41,830 | 33,251 |
Free Cash Flow | -23,313 | -40,351 | -18,845 | 14,785 |
Cash | 135,586 | 106,095 | 89,137 | 47,521 |
Basic Shares | 63,684 | 63,059 | 61,596 | 61,220 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $130,126 | $77,428 | $23,638 | $3,154 |
Gross Profit | 116,758 | 68,126 | 21,505 | 2,555 |
EBITDA | -238,090 | -168,464 | -174,246 | -168,901 |
EBIT | -239,653 | -170,222 | -175,918 | -170,059 |
Net Income | -260,602 | -184,678 | -181,119 | -68,007 |
Net Change In Cash | 130,126 | 77,428 | 23,638 | 3,154 |
Cost of Revenue | 68,429 | -41,681 | ||
Free Cash Flow | -113,879 | -136,204 | -177,709 | -151,437 |
Cash | 89,137 | 60,081 | 127,677 | 59,248 |
Basic Shares | 60,995 | 57,673 | 52,120 | 49,600 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.75 |
2025-03-31 | -$0.81 |
2024-12-31 | -$0.72 |
